Pfizer Posts Stronger-than-Expected Financial Guidance for 2025
Pfizer Inc. released its full-year 2025 financial guidance, projecting revenues between $61.0 billion and $64.0 billion, exceeding consensus estimates of $63.28 billion. The company expects revenue from COVID-19 products to remain consistent with 2024, excluding one-time Paxlovid revenue. Pfizer faces an estimated $1 billion net unfavorable revenue impact due to changes under the Inflation Reduction … Read more